What is Poly Medicure Ltd. Quarterly Revenue?

Poly Medicure Ltd. Quarterly Revenue Poly Medicure Jun-2026 Quarterly Revenue is Rs 460 Cr which is growth of 8.1% YoY.

What is Poly Medicure Ltd. Quarterly Net Profit?

Poly Medicure Ltd. Quarterly Net Profit Poly Medicure Jun-2026 Quarterly Net Profit is Rs 88 Cr which is growth of 0.2% YoY.

What is Poly Medicure Ltd. Annual Revenue?

Poly Medicure Ltd. Annual Revenue Poly Medicure Mar-2026 Annual Revenue is Rs 1,782 Cr which is growth of 5.4% YoY.

What is Poly Medicure Ltd. Annual Net Profit?

Poly Medicure Ltd. Annual Net Profit Poly Medicure Mar-2026 Annual Net Profit is Rs 336 Cr which is growth of 1.4% YoY.

What is Poly Medicure Ltd. Total Shareholders Fund?

Poly Medicure Ltd. Total Shareholders Fund Poly Medicure Mar-2025 Total Shareholders Fund is Rs 3,053 Cr which is growth of 11.2% YoY.

What is Poly Medicure Ltd. Total Assets?

Poly Medicure Ltd. Total Assets Poly Medicure Mar-2025 Total Assets is Rs 3,550 Cr which is growth of 13.0% YoY.

What is Poly Medicure Ltd. Book Value Per Share?

Poly Medicure Ltd. Book Value Per Share Poly Medicure Mar-2025 Book Value Per Share is 301 Rs which is growth of 11.2% YoY.

What is Poly Medicure Ltd. ROE?

Poly Medicure Ltd. ROE Poly Medicure Mar-2025 ROE is 11% which is growth of 1.1% YoY.

What is Poly Medicure Ltd. Cash From Operating Activity?

Poly Medicure Ltd. Cash From Operating Activity Poly Medicure Mar-2026 Cash From Operating Activity is Rs 245 Cr which is growth of 3.6% YoY.

What is Poly Medicure Ltd. Net Cash Flow?

Poly Medicure Ltd. Net Cash Flow Poly Medicure Mar-2026 Net Cash Flow is Rs 5 Cr which is growth of 438.0% YoY.

Poly Medicure Ltd.

NSE: POLYMED | BSE: 531768

Expensive Performer

Download real time

37.40(2.58%)

29.00% Fall from 52W High

59,367

NSE+BSE Volume

NSE 02 Nov, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Board Meeting

The next board meeting for Poly Medicure is on 05 Nov 2026 for the purpose of Quarterly Results See details

Poly Medicure quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Poly Medicure share price target, revenues, EPS, net income and more

Poly Medicure quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Poly Medicure Jun-2026 Quarterly Revenue is Rs 460 Cr which is growth of 8.1% YoY.
POSITIVE
Quarterly Net Profit Poly Medicure Jun-2026 Quarterly Net Profit is Rs 88 Cr which is growth of 0.2% YoY.

Poly Medicure Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	459.8	458.1	448.4	450.3	425.1	444.9	432.7	429.7	384.3	376.6	337.4	332.7	318.7
SR_Q Operating Rev.	431.1	443	418.9	416.5	384.1	421	410.9	402.5	367.4	360.9	320.9	319.9	305.6
OI_Q Other Income	28.7	15.1	29.6	33.7	41.1	24	21.8	27.2	16.8	15.7	16.6	12.8	13.2
OEXPNS_Q Operating Exp.	310.3	321.9	306.6	305.3	282.4	304.9	295.3	289.5	266.2	263.5	236.5	237.3	220.5
OEXPNS_Q Operating Exp.	310.3	321.9	306.6	305.3	282.4	304.9	295.3	289.5	266.2	263.5	236.5	237.3	220.5
OP_Q Operating Profit	120.8	121.1	112.3	111.2	101.6	116	115.6	112.9	101.2	97.4	84.4	82.6	85.1
OPMPCT_Q Operating Profit Margin %	28.03%	27.33%	26.80%	26.70%	26.46%	27.57%	28.13%	28.06%	27.54%	26.99%	26.30%	25.82%	27.85%
DEP_Q Depr.	26.5	25.5	25.1	24.2	22.8	21.3	20.8	20.1	19	16.2	15.5	15.3	15
INT_Q Interest	4.4	3.9	3.9	2.8	2.8	2.2	3.1	3.1	3	2.9	3.4	2.1	2.4
PBT_Q Profit Before Tax	118.6	106.8	106	118	117.1	116.5	113.4	116.9	96.1	94	82.1	78	80.9
TAX_Q Tax	30.5	26.2	27.6	29	29.1	29.8	28.2	29.7	23.8	23.4	20.6	18.8	20.3
NP_Q Net Profit	88.1	80.6	78.4	89.1	87.9	86.7	85.2	87.2	72.3	70.5	61.5	59.2	60.5
EPS_adj_Q EPS Adj. latest	8.7	8	7.7	8.8	8.7	8.6	8.4	8.6	7.1	7	6.1	5.8	6
NP_TTM Net profit TTM	336.2	336	342	348.8	347	331.3	315.2	291.5	263.5	251.7	238.7	224.8	210.8
EPS_TTM Basic EPS TTM	33.2	33.2	33.7	34.4	34.2	32.7	31.1	28.8	27.5	26.2	24.9	23.4	22
earnings_transcripts Earnings Transcripts
ai_summary AI Summary
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Poly Medicure competitor comparison and performance snapshot within industry

Poly Medicure annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Poly Medicure Mar-2026 Annual Revenue is Rs 1,782 Cr which is growth of 5.4% YoY.
POSITIVE
Annual Net Profit Poly Medicure Mar-2026 Annual Net Profit is Rs 336 Cr which is growth of 1.4% YoY.

Poly Medicure Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	17.3%	18.4%	1,816.6	1,782.4	1,691.6	1,365.4	1,104.3	918.1	766.7	664.8	602.5	522.8	452.9	402.9
TotalOperatingRevenues_A Operating Rev. Ann.	15.9%	17.3%	1,709.5	1,662.5	1,601.8	1,307.3	1,068	879.4	747.4	646.2	586.7	508.4	439.5	394.5
OI_A Other Income Ann.	48.9%	44.1%	107	119.9	89.8	58.2	36.3	38.7	19.3	18.6	15.8	14.4	13.4	8.4
OEXPNS_A Operating Exp. Ann.	14.8%	17.7%	1,244.1	1,216.4	1,156.4	957.7	803.6	667.2	539.1	486	454.4	388.6	347.1	310
OEXPNS_A Operating Exp. Ann.	14.8%	17.7%	1,244.1	1,216.4	1,156.4	957.7	803.6	667.2	539.1	486	454.4	388.6	347.1	310
OP_A Operating Profit Ann.	19%	16.5%	465.4	446.1	445.4	349.5	264.5	212.1	208.3	160.1	132.3	119.9	92.4	84.5
OPMPCT_A OPM Ann. %	1.5%	-1.6%		25.03%	26.33%	25.60%	23.95%	23.11%	27.17%	24.09%	21.96%	22.93%	20.39%	20.97%
TotalExpenses_A Total Exp. Ann. ⌄	15.2%	17.5%		1,327.7	1,248.7	1,030.5	867.5	723.4	593.3	543	502	426.5	376.6	338
OtherExpenses_A Other Exp. Ann.	17%	18%	354.4	369.7	344.6	274	230.7	189.5	161.6	158.7	149	133.1	119.3	100.5
EmployeeBenefitExpenses_A Employee Exp. Ann.	18.8%	19.3%	335.2	316.2	280.1	228.9	188.4	149.9	130.7	127.3	109.8	93.9	81.4	69
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	23.5%	20%		566	535.1	407.7	300.8	250.9	227.6	178.7	148.2	134.3	105.7	92.9
EBIDTPCT_A EBITDA Ann. margin %	5.3%	1.4%		31.76%	31.64%	29.86%	27.23%	27.32%	29.69%	26.89%	24.59%	25.68%	23.34%	23.05%
INT_A Interest Ann.	17.3%	11.1%	15	13.4	11.4	10.7	8.3	3.6	7.9	17.7	11.3	9.5	6.5	7.8
DEP_A Depr.	20.8%	16.2%	101.2	97.9	80.8	62.1	55.6	52.5	46.3	39.3	36.4	28.4	23	20.2
PBT_A PBT Ann.	23.7%	20.9%	449.5	447.9	442.9	334.9	236.8	194.7	173.4	121.8	100.5	96.4	76.3	64.9
TAX_A Tax Ann.	24.6%	20.6%	113.3	111.9	111.6	83.2	57.8	48.7	43.9	29.4	34.2	26.2	20.1	17.6
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	23.4%	21%		336	331.3	251.7	179	146	129.5	92.4	66.3	70.2	56.2	47.3
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	23.4%	21%	336.2	336	331.3	251.7	179	146	129.5	92.4	66.3	70.2	56.2	47.3
NETPCT_A NPM Ann. %	6.4%	3.1%		20.21%	20.68%	19.25%	16.76%	16.60%	17.32%	14.29%	11.29%	13.80%	12.78%	11.99%
EPS_adj_A EPS Adj. latest Ann.	23.3%	21%		33.2	32.7	24.8	17.7	14.4	12.8	9.1	6.5	6.9	5.5	4.7
result_notes Result Notes				Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

5.4%

2Y CAGR

14.3%

3Y CAGR

17.3%

5Y CAGR

18.4%

7Y CAGR

16.8%

10Y CAGR

16%

Total Revenue Annual growth is lower than historical averages.

Net Profit Ann.

1Y CHG

1.4%

2Y CAGR

15.5%

3Y CAGR

23.4%

5Y CAGR

21%

7Y CAGR

26.1%

10Y CAGR

21.7%

Net Profit Annual growth is lower than historical averages.

Operating Exp. Ann.

1Y CHG

5.2%

2Y CAGR

12.7%

3Y CAGR

14.8%

5Y CAGR

17.7%

7Y CAGR

15.1%

10Y CAGR

14.6%

Operating Expenses Annual Cr growth is lower than historical averages.

Poly Medicure balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Poly Medicure Mar-2025 Total Shareholders Fund is Rs 3,053 Cr which is growth of 11.2% YoY.
POSITIVE
Total Assets Poly Medicure Mar-2025 Total Assets is Rs 3,550 Cr which is growth of 13.0% YoY.

Poly Medicure Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	35.2%	26.2%	3,052.7	2,744.2	1,458.3	1,234.1	1,077	954	429.3	379.8	334.5	269.2	223.8
EQCAP_A Equity Share Capital Ann.	1.8%	1.1%	50.7	50.7	48	48	48	47.9	44.1	44.1	44.1	44.1	22.1
TotalShareCapital_A Total Share Capital Ann.	1.8%	1.1%	50.7	50.7	48	48	48	47.9	44.1	44.1	44.1	44.1	22.1
ReservesAndSurplus_A Reserves Plus Surplus Ann.	36.3%	27.1%	3,002	2,693.6	1,410.3	1,186.2	1,029	906.1	385.2	335.7	290.4	225.1	201.8
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	36.3%	27.1%	3,002	2,693.6	1,410.3	1,186.2	1,029	906.1	385.2	335.7	290.4	225.1	201.8
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	31%	-0.8%	78	54.3	35.6	34.7	53.7	81.4	134.5	118.3	104	71.6	49.1
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	55.6%	34.9%	58	42.9	24.5	15.4	16.1	13	14.5	18.7	15.7	14.8	11.8
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-10.5%	-12.1%	3.3	4.3	5.8	4.6	4.2	6.3	6.5	5.8	7	5.8	3.6
CL_A Total Current Liabilities Ann. ⌄	15.9%	22.5%	419.3	341.8	327.5	269	203.3	152	176.2	135	116.2	108.1	102.9
TradePayables_A Trade Payables Ann.	2.7%	8.6%	84.7	76.8	89	78.1	77.9	56.1	60.5	49.6	43.2	41	29.6
OtherCurrentLiabilities_A Other Current Liabilities Ann.	9.5%	6.5%	88.4	94.8	78.5	67.4	46.3	64.5	71	50	45.9	38.3	38
ShortTermProvisions_A ST Provisions Ann.	-30.7%	-12.9%	0.2	0.4	0.5	0.6	0.4	0.4	0.4	0.3	0.3	0.4	4.9
TL_A Total Capital Plus Liabilities Ann.	32.2%	24.5%	3,550	3,140.4	1,821.4	1,537.8	1,334	1,187.4	740	633.2	554.6	448.9	375.9
FixedAssets_A Fixed Assets Ann. ⌄	24.7%	26.1%	1,309.8	1,140.1	902.1	676.1	494.3	410.7	352.2	290.6	277.8	221.1	191
TangibleAssets_A Tangible Assets Ann.	27.4%	26.7%	1,205.7	1,032.6	815.6	582.6	432.8	369.4	309.7	255.1	242.9	188.2	170.5
IntangibleAssets_A Intangible Assets Ann.	-2.3%	-2.4%	13.8	14.7	15.3	14.8	14.7	15.6	14.5	13.5	13.2	12.3	6.7
CapitalWorkInProgress_A Capital Work In Progress Ann.	7.6%	43.8%	90.3	89.5	66.7	72.5	37.1	14.7	16.7	9.3	9.7	11.8	2.9
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	34.7%	30.1%	1,910.4	1,280	1,029.6	782.2	593	512.1	446.7	351.8	304.8	248.8	212.9
NonCurrentInvestments_A Non Current Investments Ann.	106.8%	66.1%	503.9	70.7	81.1	57	46.9	39.8	42	42	7.7	5.6	5.6
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-										0	12.9
OtherNonCurrentAssets_A Other Non Current Assets Ann.	25.3%	9.4%	96.6	69.2	46.4	49.1	51.7	61.6	52.4	19.2	19.3	22	3.4
CA_A Total Current Assets Ann. ⌄	29.5%	19.4%	1,639.6	1,860.3	791.8	755.6	741	675.4	293.3	281.3	249.8	200.1	163
CurrentInvestments_A Current Investments Ann.	84%	16.5%	739.2	1,056.6	139.5	118.6	336.6	345	15.9	0.3	10.6
TradeReceivables_A Trade Receivables Ann.	26%	24.2%	442.3	340.1	259.3	221	191.5	149.6	120.5	124.1	111.9	95.3	80.3
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-37.7%	9.2%	42.6	143.2	137	176.4	8.3	27.4	22.4	53.2	20.4	22.4	21.5
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-30.7%	18.5%	0.7	0.3	0.2	2.1	0.3	0.3	0.1	0.2	0.2	0.1	12.8
OtherCurrentAssets_A Other Current Assets Ann.	34.6%	25%	133.5	70.3	62.8	54.7	54	43.7	33.4	29.4	38.2	24.4	7.8
TA_A Total Assets Ann.	32.2%	24.5%	3,550	3,140.4	1,821.4	1,537.8	1,334	1,187.4	740	633.2	554.6	448.9	375.9
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-	-	-	357	230	164	169.6	99.2	114.5	67.5	65.2	74	42.2
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-	-	-	38.6	38.6	38.6	38.6	38.6	38.6	38.6	38.6	38.6	16.5
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	-	-						2.2	2.2	2.1	6.9	6.9
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-	-	1,056.6	139.5	118.6	336.6	345	15.9	0.3	10.6

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

13%

2Y CAGR

39.6%

3Y CAGR

32.2%

5Y CAGR

24.5%

7Y CAGR

27.9%

10Y CAGR

25.2%

Total Assets Annual growth is lower than historical averages.

Total Current Liabilities Ann.

1Y CHG

22.7%

2Y CAGR

13.2%

3Y CAGR

15.9%

5Y CAGR

22.5%

7Y CAGR

17.6%

10Y CAGR

15.1%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

11.2%

2Y CAGR

44.7%

3Y CAGR

35.2%

5Y CAGR

26.2%

7Y CAGR

34.7%

10Y CAGR

29.9%

Total ShareHolders Funds Annual growth is lower than historical averages.

Poly Medicure ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Poly Medicure Mar-2025 Book Value Per Share is 301 Rs which is growth of 11.2% YoY.
POSITIVE
ROE Poly Medicure Mar-2025 ROE is 11% which is growth of 1.1% YoY.

Poly Medicure Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
BVSH_A BVSH Ann.	32.8%	24.8%	301.2	270.8	152	128.6	112.3	99.5	48.7	43	37.9	30.5	50.7
ROA_A RoA Ann. %	-6.7%	-2.8%	9.46%	10.55%	13.82%	11.64%	10.94%	10.90%	12.48%	10.46%	12.65%	12.52%	12.58%
ROE_A ROE Ann. %	-8.8%	-4.1%	11.00%	12.07%	17.26%	14.50%	13.55%	13.57%	21.52%	17.45%	20.98%	20.87%	21.13%
ROCE_A ROCE Ann. %	-8.2%	-3.1%	14.95%	16.23%	23.13%	19.31%	17.53%	17.50%	24.73%	22.44%	24.14%	24.28%	26.61%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	6.5%	2.3%	34.04%	33.40%	31.18%	28.16%	28.52%	30.45%	27.65%	25.25%	26.40%	24.05%	23.53%
PBITMargin_A EBIT Ann. Margin %	7%	3%	28.15%	28.36%	26.43%	22.95%	22.55%	24.25%	21.57%	19.05%	20.81%	18.82%	18.41%
PBTMargin_A PBT Ann. Margin %	6.7%	3%	26.94%	27.64%	25.61%	22.17%	22.14%	23.19%	18.84%	17.12%	18.95%	17.35%	16.44%
NETPCT_A NPM Ann. %	6.4%	3.1%	20.21%	20.68%	19.25%	16.76%	16.60%	17.32%	14.29%	11.29%	13.80%	12.78%	11.99%
ASETTO_A Asset Turnover Ann. %	-10.6%	-9%	0.5	0.7	0.8	0.7	0.7	0.8	0.9	1	1	1.1	1.1
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	11.7%	-2.4%	3.9	5.4	2.4	2.8	3.7	4.4	1.7	2.1	2.2	1.9	1.6
QuickRatio_A Quick Ratio Ann.	15.1%	-2.9%	3.2	4.7	1.8	2.1	2.9	3.7	1.1	1.5	1.6	1.3	1.2
DividendPayoutNP_A Dividend Payout to NP Ann.	0%	-	0.1	0.1	0.1	0.1	0.2		0.4	0.3	0.1	0.2	1.1
EarningRetention_A Earning Retention Ann. %	-	-	-	90.83%	88.57%	86.61%	83.59%		80.90%			80.38%	66.42%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-	-	92.63%	90.83%	89.79%	87.93%		86.60%			86.07%	76.46%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-	-	92.63%	90.83%	89.79%	87.93%		86.60%			86.07%	76.46%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	10.5%	9.2%	12,275.7	22,744.9	15,271.6	9,102.6	9,200.1	7,902.5	2,211.6	1,988.5	2,291.6	2,455.3	1,280.5
EVPerNetSales_A EV Per Net Sales Ann.	-4.5%	-6.9%	7.4	14.2	11.7	8.5	10.5	10.6	3.4	3.4	4.5	5.6	3.3
PBV_A Price To Book Value Adjusted	-24.7%	-19.9%	4.94	5.85	9.79	11.56	13.24	14.94	30.57	34.55	39.22	48.74	29.3
EVPerEBITDA_A EV Per EBITDA Ann.	-10.5%	-9%	21.7	42.5	37.5	30.3	36.7	34.7	12.4	13.4	17.1	23.2	13.8
MarketCapPerSales_A Market Cap Per Sales Ann.	-5.3%	-7%	7.3	14.2	11.7	8.6	10.4	10.5	3.2	3.3	4.3	5.5	3.1
RetentionRatios_A Retention Ratio Ann. %	-	-	-	90.82%	88.56%	86.60%	83.58%		80.89%			80.37%	66.41%
EYield_A Earnings Yield Ann.	-	-	0	0	0	0	0	0	0	0	0	0	0
DEBT_CE_A Total Debt to Total Equity Ann.	0%	0%	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.3	0.3	0.3	0.3

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

-8.9%

2Y CAGR

-20.2%

3Y CAGR

-8.8%

5Y CAGR

-4.1%

7Y CAGR

-6.4%

10Y CAGR

-6.3%

ROE Annual % is falling faster than historical averages.

RoA Ann. %

1Y CHG

-10.3%

2Y CAGR

-17.3%

3Y CAGR

-6.7%

5Y CAGR

-2.8%

7Y CAGR

-1.4%

10Y CAGR

-2.8%

RoA Annual % is falling faster than historical averages.

Current Ratio Ann.

1Y CHG

-27.8%

2Y CAGR

27.5%

3Y CAGR

11.7%

5Y CAGR

-2.4%

7Y CAGR

9.2%

10Y CAGR

9.3%

Current Ratio Annual is falling faster than historical averages.

Poly Medicure cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Poly Medicure Mar-2026 Cash From Operating Activity is Rs 245 Cr which is growth of 3.6% YoY.
POSITIVE
Net Cash Flow Poly Medicure Mar-2026 Net Cash Flow is Rs 5 Cr which is growth of 438.0% YoY.

Poly Medicure Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	8%	16.1%	245.2	236.7	256.1	194.9	126.3	116.4	126.9	112.3	75.5	55	62.1
PBT_A PBT Ann.	23.7%	20.9%	447.9	442.9	334.9	236.8	194.7	173.4	121.8	100.5	96.4	76.3	64.9
INT_A Interest Ann.	17.3%	11.1%	13.4	11.4	10.7	8.3	3.6	7.9	17.7	11.3	9.5	6.5	7.8
TAX_A Tax Ann.	24.6%	20.6%	111.9	111.6	83.2	57.8	48.7	43.9	29.4	34.2	26.2	20.1	17.6
CFI_A Cash from Investing Act. Ann.	-	-	-267.8	-1,191.2	-237	-187.2	-88.7	-434.4	-105.7	-103.9	-87.1	-54.2	-30.3
CFA_A Cash from Financing Act. Ann.	-	-38.5%	28	952.9	-17.3	-7.9	-39.7	318.9	-22.3	-9.2	14.5	-0.8	-30.9
NCF_A Net Cash Flow Ann. ⌄	-	43.1%	5.4	-1.6	1.8	-0.3	-2.2	0.9	-1	-0.8	2.9	0.1	1
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	0%	-20.6%	0.6	2.1	0.4	0.6	2.8	1.9	2.9	3.7	0.8	0.7	11.7
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	145.2%	16.1%	5.9	0.6	2.1	0.4	0.6	2.8	1.9	2.9	3.7	0.8	12.7

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

3.6%

2Y CAGR

-2.2%

3Y CAGR

5Y CAGR

16.1%

7Y CAGR

11.8%

10Y CAGR

14.7%

Cash from Operating Activity Annual growth is lower than historical averages.

Cash from Financing Act. Ann.

1Y CHG

-97.1%

5Y CAGR

-38.5%

Cash from Financing Annual Activity is falling faster than historical averages.

Poly Medicure investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

Poly Medicure quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Poly Medicure - Forecaster

Forecaster Analyst Estimates for Poly Medicure share price target, revenues, EPS, net income and more